ArticleEuropean journal of medical research2026
Association between heavy metals exposure and depression: findings of the NHANES from 2003 to 2020.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeavy metals are recognized neurotoxicants implicated in depression, yet limited research examines combined metal impacts. This study aimed to investigate the joint effect of heavy metals on depression and identify key contributors within the mixture.
methodsAnalyzing National Health and Nutrition Examination Survey data, adults with complete data on nine urinary metals (antimony, barium, cadmium, cobalt, cesium, molybdenum, lead, thallium, and tungsten), three blood metals (cadmium, mercury, and lead), depression status, and key covariates were assessed via four methods (multivariate logistic regression, restricted cubic spline (RCS) regression, weighted quantile sum (WQS) regression, and Bayesian kernel machine regression (BKMR)) to evaluate metal-depression associations.
resultsAmong 8814 participants (731 with depression), those with depression showed higher urine and blood cadmium levels, but lower blood mercury and urine thallium levels compared to controls. Adjusted analyses linked elevated urine antimony (OR = 1.34, p = 0.029) and tungsten (OR = 1.42, p = 0.008) to increased depression risk, while higher urine thallium (OR = 0.52, p < 0.001) and blood mercury (OR = 0.7, p = 0.005) reduced risk. RCS analysis revealed nonlinear relationships between depression and urine cadmium (p = 0.004), cobalt (p = 0.005), lead (p = 0.024), antimony (p < 0.001), tungsten (p < 0.001), as well as blood cadmium (p < 0.001) and mercury (p < 0.001). The mixture analysis revealed both positive and negative exposure-response relationships, which were, respectively, dominated by urinary tungsten (29.3% weight in the WQS index) and blood mercury (44% weight). BKMR analysis confirmed multi-metal co-exposure elevates depression risk, and urinary barium showed the highest BKMR-derived posterior inclusion probability (PIP = 0.448).
conclusionOur findings link heavy metal mixtures to depression, identifying tungsten and antimony as risk contributors, versus inverse associations for mercury and thallium, with barium as a key interactive factor. Further studies are needed to validate these metal-specific impacts and uncover additional depression-linked metals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.